Sensex Dips 142 Points Nifty Holds Above 23900 as Mid and SmallCaps Shine NBCC Reports 3878 YoY Profit Growth in Q4FY26 Declares Dividend of 046 HighYield Savings Rates Reach Up to 410 APY as of May 22 2026 What Savers Should Know Piper Sandler Warns Strait of Hormuz Closure Could Push Oil to New Highs This Summer Morgan Stanley Suggests Wall Street May Be Underestimating Microsoft AI Revenue Potential TikTok and YouTube Face Regulatory Scrutiny Over Child Safety Standards from UK Watchdog NX Q1 2026 Earnings Earnings Beat Estimates Despite Negative EPS BKKT Q1 2026 Earnings Wide EPS Miss Disappoints Revenue Data Withheld PLMR Q1 2026 Earnings EPS Surpasses Estimates by 301 Amid Modest Stock Pullback BNR Q3 2022 Earnings Narrower Loss Surprises Wall Street as Stock Drops 11 on Broader Biotech Selloff RILYP Q1 2024 Earnings Negative EPS Amid Preferred Stock Challenges PECO Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Freshpet Inc FRPT Experiences Modest Decline as Pet Food Sector Holds Steady AgEagle Aerial Systems UAVS Posts Modest Gain at 106 Resistance at 111 in Focus Upbound Group Inc UPBD Rises 151 Testing Resistance Near 19 Amid Volume Patterns FMX Stock Holds Steady Near 121 as Support and Resistance Levels Define Trading Range Corcept Therapeutics CORT Holds Near Support Amid Modest Gains Resistance at 6287 in Focus AnheuserBusch InBev Shares Dip as Quarterly Sales Fall Short of Analyst Expectations Tenax Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Clinical Development Eagle Materials EXP Holds Steady Near Support After Modest Uptick Beeline Holdings Inc BLNE Declines Sharply Approaches Key Support Level Bain Capital GSS BCSS Holds Steady at 1020 Key Levels in Focus The Marzetti Company MZTI Gains Momentum Breaking Above Key Support Levels OFS Credit Company Inc Preferred Stock OCCIM Holds Steady Near 2530 Amid Narrow Trading Range Lockheed Martin LMT Gains 097 as Defense Sector Holds Firm Support Cadeler AS CDLR Shows Modest Uptick Testing Key Resistance Zone Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187